Health Communication Impact, LLC — Department of Health and Human Services SBIR Phase II: 100

Description

DESCRIPTION provided by applicant Racial and ethnic minorities older adults and those from rural communities continue to be underrepresented in cancer and other clinical trials research despite annual spending on patient recruitment in excess of $ billion While many individual studies have demonstrated that targeted outreach and education to underrepresented patients and engagement of front line providers in community hospitals can help boost participation in clinical trials few of these strategies have evolved into scalable systems that cn support recruitment efforts across many organizations simultaneously with demonstrated efficacy MIYO Make It Your Own is an online tool that addresses this challenge MIYO helps healthcare organizations develop and use professional quality recruitment materials to increase research participation among underrepresented groups In minutes organizations can create their own versions of audience tested small media for the specific patients they serve by choosing from a menu of approaches recommended by the Guide to Community Preventive Services then customizing them by choosing from a library of images messages and graphic designs Creations can be printed e mailed texted used online or distributed in other ways to target audiences In a wide range of Phase I equivalent studies MIYO has been used to promote HPV vaccination use of tobacco quit lines colorectal cancer screening and use of clinical trials recruitment materials Findings from this research shows that MIYO is well liked and easy to use helpful in designing outreach and education products that are targeted for vulnerable population sub groups and effective in increasing audience responses like a calling CANCER The proposed Direct to Phase II study will expand the Clinical Trials Participation module in MIYO and evaluate its effectiveness in getting patients to enter Pioneers a research recruitment registry In partnership with the Midwest Cancer Alliance we will randomize its community hospital and health center members to either an active MIYO condition or delayed use control and compare rates of enrollment overall and in priority sub groups months pre and post implementation of MIYO Increased and more diverse participation in clinical trials will improve the lives of cancer patients and their families and elp eliminate cancer health disparities in the U S population PUBLIC HEALTH RELEVANCE The burden of cancer on U S adults is tremendous and disproportionate among certain population sub groups Clinical trials are one of the main pathways to reducing that burden but participation rates are low especially among those most affected by cancer Our study will examine the uptake and effects of an online tool to help healthcare organizations develop and use evidence based professional quality recruitment materials to increase research participation in underrepresented groups